That discovery prompted us to create a novel animal model for AD, transgenic (TG) mice that have an upregulated expression of the β-subunit of ASAH1 controlled by the involucrin promoter (ASAH1b TG mice), which should express ASAH1b exclusively in the upper layers of the epidermis. The gene discussed is ASAH1; the disease is Alzheimer disease.